Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Verrica Pharmaceuticals I...

    NASDAQ: VRCA · Real-Time Price · USD
    0.62
    -0.05 (-7.98%)
    At close: Jun 13, 2025, 3:59 PM
    0.62
    -0.19%
    After-hours: Jun 13, 2025, 04:48 PM EDT

    Verrica Pharmaceuticals Statistics

    Share Statistics

    Verrica Pharmaceuticals has 92.49M shares outstanding. The number of shares has increased by 116.36% in one year.

    Shares Outstanding

    n/a
    		 92.49M

    Shares Change (YoY)

    n/a
    		 116.36%

    Shares Change (QoQ)

    n/a
    		 1.34%

    Owned by Institutions (%)

    n/a
    		 63.94%

    Shares Floating

    n/a
    		 50.08M

    Failed to Deliver (FTD) Shares

    n/a
    		 46,522

    FTD / Avg. Volume

    n/a
    		 12.2%

    Short Selling Information

    The latest short interest is 2.27M, so 2.45% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.27M

    Short % of Shares Out

    n/a
    		 2.45%

    Short % of Float

    n/a
    		 4.41%

    Short Ratio (days to cover)

    n/a
    		 9.82

    Valuation Ratios

    The PE ratio is -0.47 and the forward PE ratio is -2.87. Verrica Pharmaceuticals's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.47

    Forward PE

    n/a
    		 -2.87

    PS Ratio

    n/a
    		 4.79

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 -3.68

    P/FCF Ratio

    n/a
    		 -0.59

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Verrica Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.76, with a Debt / Equity ratio of -4.66.

    Current Ratio

    n/a
    		 1.76

    Quick Ratio

    n/a
    		 1.68

    Debt / Equity

    n/a
    		 -4.66

    Debt / EBITDA

    n/a
    		 -0.7

    Debt / FCF

    n/a
    		 -0.75

    Interest Coverage

    n/a
    		 -7

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $106,563.38

    Profits Per Employee

    n/a
    		 $-1,078,577.46

    Employee Count

    n/a
    		 71

    Asset Turnover

    n/a
    		 0.14

    Inventory Turnover

    n/a
    		 0.75

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -92.36% in the last 52 weeks. The beta is 1.76, so Verrica Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.76

    52-Week Price Change

    n/a
    		 -92.36%

    50-Day Moving Average

    n/a
    		 0.53

    200-Day Moving Average

    n/a
    		 0.92

    Relative Strength Index (RSI)

    n/a
    		 56.28

    Average Volume (20 Days)

    n/a
    		 381,174

    Income Statement

    In the last 12 months, Verrica Pharmaceuticals had revenue of 7.57M and earned -76.58M in profits. Earnings per share was -1.48.

    Revenue

    n/a
    		 7.57M

    Gross Profit

    n/a
    		 5.71M

    Operating Income

    n/a
    		 -65.92M

    Net Income

    n/a
    		 -76.58M

    EBITDA

    n/a
    		 -65.9M

    EBIT

    n/a
    		 -67.17M

    Earnings Per Share (EPS)

    n/a
    		 -1.48
    Full Income Statement

    Balance Sheet

    The company has 46.33M in cash and 45.94M in debt, giving a net cash position of 390K.

    Cash & Cash Equivalents

    n/a
    		 46.33M

    Total Debt

    n/a
    		 45.94M

    Net Cash

    n/a
    		 390K

    Retained Earnings

    n/a
    		 -307.03M

    Total Assets

    n/a
    		 42.18M

    Working Capital

    n/a
    		 10.08M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -60.93M and capital expenditures -27K, giving a free cash flow of -60.95M.

    Operating Cash Flow

    n/a
    		 -60.93M

    Capital Expenditures

    n/a
    		 -27K

    Free Cash Flow

    n/a
    		 -60.95M

    FCF Per Share

    n/a
    		 -1.18
    Full Cash Flow Statement

    Margins

    Gross margin is 75.51%, with operating and profit margins of -871.25% and -1012.15%.

    Gross Margin

    n/a
    		 75.51%

    Operating Margin

    n/a
    		 -871.25%

    Pretax Margin

    n/a
    		 -1012.15%

    Profit Margin

    n/a
    		 -1012.15%

    EBITDA Margin

    n/a
    		 -870.98%

    EBIT Margin

    n/a
    		 -871.25%

    FCF Margin

    n/a
    		 -805.63%

    Dividends & Yields

    VRCA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VRCA is $6, which is 867.7% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $6

    Price Target Difference

    n/a
    		 867.7%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -14.04

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist